|
|
|
|

|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
| Date |
Name |
Title |
Type |
Shares Traded |
Price Range  |
| Feb 5, 2008 |
topper james n |
Director |
Buy |
32,864 |
10.32 - 10.50 |
| Feb 4, 2008 |
topper james n |
Director |
Buy |
33,823 |
10.32 - 10.50 |
| Jun 4, 2008 |
crowley john f |
Officer |
Automatic Sell |
5,000 |
10.29 - 10.50 |
| Jul 16, 2009 |
crowley john f |
Officer |
Automatic Sell |
3,500 |
10.29 |
| Jul 14, 2009 |
crowley john f |
Officer |
Automatic Sell |
4,748 |
10.28 |
| Nov 3, 2008 |
crowley john f |
Officer |
Automatic Sell |
10,000 |
10.27 - 10.29 |
| May 2, 2008 |
crowley john f |
Officer |
Automatic Sell |
4,795 |
10.26 - 10.72 |
| Jul 9, 2009 |
crowley john f |
Officer |
Automatic Sell |
1,652 |
10.24 |
| Nov 3, 2008 |
bloch stephen m |
Director |
Automatic Sell |
3,000 |
10.24 |
| Feb 1, 2008 |
dentzer james e |
Officer |
Disposition (Non Open Market) |
220 |
10.24 |
| Jan 31, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
8,800 |
10.21 - 10.50 |
| Jan 31, 2008 |
topper james n |
Director |
Buy |
8,800 |
10.21 - 10.50 |
| Jun 2, 2008 |
dentzer james e |
Officer |
Disposition (Non Open Market) |
220 |
10.20 |
| Mar 10, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
4,740 |
10.19 - 10.50 |
| Mar 10, 2008 |
topper james n |
Director |
Buy |
4,740 |
10.19 - 10.50 |
| Feb 5, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
35,536 |
10.16 - 10.31 |
| Feb 5, 2008 |
topper james n |
Director |
Buy |
35,536 |
10.16 - 10.31 |
| Jan 2, 2008 |
crowley john f |
Officer |
Automatic Sell |
9,600 |
10.13 - 10.67 |
| Jun 2, 2008 |
crowley john f |
Officer |
Automatic Sell |
1,300 |
10.12 - 10.29 |
| Feb 13, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
6,200 |
10.10 - 10.43 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|